Vancouver, British Columbia – TheNewswire - January 27, 2026 – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “Company” or “MindBio”), a biotechnology company that conducts clinical health research and has developed a world first AI prediction tool for drug and alcohol intoxication detection by a simple analysis of the voice, is pleased to announce the Company is targeting the global digital health diagnostics market with a first mover advantage in using speech as a diagnostic ...